Pyrazines
Medchemexpress LLC NPS 2390 | 226878-01-9 | 99.9% | 307.39 | 1 ML
NPS 2390 is a noncompetitive antagonist of mGluR1 and mGluR5. It is also identified as a potent inhibitor of CaSR (calcium-sensing receptor). This product is intended for research use only and is not sold to patients.
- Noncompetitive antagonist of mGluR1 and mGluR5.
- Potent CaSR (calcium-sensing receptor) inhibitor.
- Available in various quantities (5 mg, 10 mg, 25 mg, 50 mg, 100 mg solid; 10 mM * 1 mL in DMSO solution).
- High purity: 99.90%.
Medchemexpress LLC NPS 2390 | 226878-01-9 | 99.9% | 307.39 | 100 MG
NPS 2390 is a noncompetitive antagonist of mGluR1 and mGluR5. It also functions as a potent calcium-sensing receptor (CaSR) inhibitor.
- Noncompetitive antagonist of mGluR1 and mGluR5
- Potent CaSR inhibitor
Medchemexpress LLC NPS 2390 | 226878-01-9 | 99.9% | 307.39 | 10 MG
NPS 2390 is a noncompetitive antagonist of mGluR1 and mGluR5. It is also a potent CaSR (calcium-sensing receptor) inhibitor.
- Noncompetitive antagonist of mGluR1 and mGluR5.
- Potent CaSR (calcium-sensing receptor) inhibitor.
- For research use only.
Medchemexpress LLC N-(1-adamantyl)quinoxaline-2-carboxamide | 226878-01-9 | MFCD05865239 | 99.9% | 307.39 g·mol⁻¹ | C19H21N3O | 5 MG
NPS 2390 is a small-molecule research compound described as a noncompetitive antagonist of metabotropic glutamate receptors mGluR1 and mGluR5 and as an inhibitor of the calcium-sensing receptor (CaSR). It is supplied for laboratory research use only and is accompanied by technical documentation including a datasheet, COA, and SDS.
- Noncompetitive antagonist of mGluR1 and mGluR5.
- Inhibitor of the calcium-sensing receptor (CaSR).
- Molecular formula C19H21N3O; molecular weight 307.39 g·mol⁻¹.
- High purity (~99.9%) suitable for biochemical and cellular assays.
- Available as solid quantities and as a 10 mM solution in DMSO.
- Supplied for research use only with supporting COA, SDS, and handling instructions.